Search research articles
Contact Us
Filters
Showing results (81-90 of 158) with videos related to
Page
of 16
Sort By:
JAMA
|
February 15, 2017
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial
Julie Nangia, Tao Wang, Cynthia Osborne, et al.
Breast Cancer Research and Treatment
|
November 2, 2005
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
Yee-Lu Tham, L Fernando Gomez, Syed Mohsin, et al.
Molecular Cancer Therapeutics
|
March 30, 2018
Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
Monica E Wielgos, Zhuo Zhang, Rajani Rajbhandari, et al.
Cancer
|
July 23, 2003
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials
John F R Robertson, C Kent Osborne, Anthony Howell, et al.
Journal of the National Cancer Institute
|
May 1, 2008
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li, Michael T Lewis, Jian Huang, et al.
Journal of the National Cancer Institute
|
January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice
Tracy E Strecker, Qiang Shen, Yun Zhang, et al.
Cancer Research
|
February 28, 2016
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
Petra den Hollander, Kathryn Rawls, Anna Tsimelzon, et al.
Breast Cancer Research and Treatment
|
June 21, 2019
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
Polly Niravath, Susan G Hilsenbeck, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2010
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts
Mothaffar F Rimawi, Lisa S Wiechmann, Yen-Chao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006
Mothaffar F Rimawi, Ingrid A Mayer, Andres Forero, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 158) with videos related to
Sort By:
Page
of 16
JAMA
|
February 15, 2017
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial
Julie Nangia, Tao Wang, Cynthia Osborne, et al.
Breast Cancer Research and Treatment
|
November 2, 2005
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
Yee-Lu Tham, L Fernando Gomez, Syed Mohsin, et al.
Molecular Cancer Therapeutics
|
March 30, 2018
Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
Monica E Wielgos, Zhuo Zhang, Rajani Rajbhandari, et al.
Cancer
|
July 23, 2003
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials
John F R Robertson, C Kent Osborne, Anthony Howell, et al.
Journal of the National Cancer Institute
|
May 1, 2008
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li, Michael T Lewis, Jian Huang, et al.
Journal of the National Cancer Institute
|
January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice
Tracy E Strecker, Qiang Shen, Yun Zhang, et al.
Cancer Research
|
February 28, 2016
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
Petra den Hollander, Kathryn Rawls, Anna Tsimelzon, et al.
Breast Cancer Research and Treatment
|
June 21, 2019
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
Polly Niravath, Susan G Hilsenbeck, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2010
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts
Mothaffar F Rimawi, Lisa S Wiechmann, Yen-Chao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006
Mothaffar F Rimawi, Ingrid A Mayer, Andres Forero, et al.
Page
of 16